Characterization of cofactors, substrates and inhibitor binding to flavoenzyme quinone reductase 2 by automated supramolecular nano-electrospray ionization mass spectrometry

International Journal of Mass Spectrometry

Volumn 312, Issue , 2012, Pages 87-96

  Antoine, Mathias ^a   Marcheteau, Estelle ^a   Delagrange, Philippe ^b   Ferry, Gilles ^a   Boutin, Jean A ^a  

^a Biotechnologie Pharmacologie Moléculaire et Cellulaire   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Flavoprotein; Melatonin; Quinone reductase; Resveratrol; Supramolecular mass spectrometry

Indexed keywords

EID: 84857058412     PISSN: 13873806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijms.2011.07.011     Document Type: Article

References (35)

1. F. Vella, G. Ferry, P. Delagrange, and J.A. Boutin NRH:quinone reductase 2: an enzyme of surprises and mysteries Biochem. Pharmacol. 71 2005 1 12 (Pubitemid 41715231)
2. D.J. Long, and A.K. Jaiswal NRH:quinone oxidoreductase2 (NQO2) Chem. Biol. Interact. 129 2000 99 112 (Pubitemid 32061056)
3. A.K. Jaiswal, P. Burnett, M. Adesnik, and O.W. McBride Nucleotide deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6 Biochemistry 29 1990 1899 1906 (Pubitemid 20074738)
4. S. Liao, and H.G. Williams-Ashman Enzymatic oxidation of some non-phosphorylated derivatives of dihydronicotinamide Biochem. Biophys. Res. Commun. 4 1961 208 213
5. Q. Zhao, X.L. Yang, W.D. Holtzclaw, and P. Talalay Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase) Proc. Natl. Acad. Sci. U.S.A 94 1997 1669 1674 (Pubitemid 27113893)
6. D.J. Long, K. Iskander, A. Gaikwad, M. Arin, D.R. Roop, R. Knox, R. Barrios, and A.K. Jaiswal Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity J. Biol. Chem. 277 2002 46131 46139 (Pubitemid 35417602)
7. V. Radjendirane, P. Joseph, Y.H. Lee, S. Kimura, A.J. Klein-Szanto, F.J. Gonzalez, and A.K. Jaiswal Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity J. Biol. Chem. 273 1998 7382 7389 (Pubitemid 28152759)
8. F. Mailliet, G. Ferry, F. Vella, K. Thiam, P. Delagrange, and J.A. Boutin Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3 FEBS Lett. 578 2004 116 120 (Pubitemid 39576111)
9. K. Reybier, P. Perio, G. Ferry, J. Bouajila, P. Delagrange, J.A. Boutin, and F. Nepveu Insights into the Redox Cycle of Human Quinone Reductase 2 Free Radic Res. 2011 10.3109/10715762.2011.605788 [Epub ahead of print]
10. C.E. Foster, M.A. Bianchet, P. Talalay, Q. Zhao, and L.M. Amzel Crystal structure of human quinone reductase type 2, a metalloflavoprotein, Biochemistry 38 1999 9881 9886
11. J.J Kwiek, T.A. Haystead, and J. Rudolph Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines Biochemistry 43 2004 4538 4547 (Pubitemid 38500583)
12. M.A. Bianchet, S.B. Erdemli, and L.M. Amzel Structure, function, and mechanism of cytosolic quinone reductases Vitam. Horm. 78 2008 63 84
13. L. Buryanovskyy, Y. Fu, M. Boyd, Y. Ma, T.C. Hsieh, J.M. Wu, and Z. Zhang Crystal structure of quinone reductase 2 in complex with resveratrol Biochemistry 43 2004 11417 11426 (Pubitemid 39186963)
14. Y. Fu, L. Buryanovskyy, and Z. Zhang Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954 Biochem. Biophys. Res. Commun. 336 2005 332 338 (Pubitemid 41253438)
15. B. Calamini, B.D. Santarsiero, J.A. Boutin, and A.D. Mesecar Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2 Biochem. J. 413 2008 81 91 (Pubitemid 351946864)
16. M.F. Boussard, S. Truche, A. Rousseau-Rojas, S. Briss, S. Descamps, M. Droual, M. Wierzbicki, G. Ferry, V. Audinot, P. Delagrange, and J.A. Boutin New ligands at the melatonin binding site MT(3) Eur. J. Med. Chem. 41 2006 306 320
17. F. Mailliet, G. Ferry, F. Vella, S. Berger, F. Coge, P. Chomarat, C. Mallet, S.P. Guenin, G. Guillaumet, M.C. Viaud-Massuard, S. Yous, P. Delagrange, and J.A. Boutin Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme Biochem. Pharmacol. 71 2005 74 88 (Pubitemid 41713529)
18. G. Ferry, S. Hecht, S. Berger, N. Moulharat, F. Coge, G. Guillaumet, V. Leclerc, S. Yous, P. Delagrange, and J.A. Boutin Old and new inhibitors of quinone reductase 2 Chem. Biol. Interact. 186 2010 103 109
19. C.E. Benoit, S. Bastianetto, J. Brouillette, Y. Tse, J.A. Boutin, P. Delagrange, T. Wong, P. Sarret, and R. Quirion Loss of quinone reductase 2 function selectively facilitates learning behaviors J. Neurosci. 30 2010 12690 12700
20. J.A. Boutin, E. Marcheteau, P. Hennig, N. Moulharat, S. Berger, P. Delagrange, J.P. Bouchet, and G. Ferry MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate J. Pineal Res. 45 2008 524 531
21. O. Nosjean, M. Ferro, F. Coge, P. Beauverger, J.M. Henlin, F. Lefoulon, J.L. Fauchere, P. Delagrange, E. Canet, and J.A. Boutin Identification of the melatonin-binding site MT3 as the quinone reductase 2 J. Biol. Chem. 275 2000 31311 31317
22. A. Aliverti, B. Curti, M.A. Vanoni, Identifying, and F.A.D. quantitating FMN in simple and in iron-sulfur-containing flavoproteins Methods Mol. Biol. 131 1999 9 23
23. R. Jockers, P. Maurice, J.A. Boutin, and P. Delagrange Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br. J. Pharmacol. 154 2008 1182 1195 (Pubitemid 351992057)
24. J.A. Boutin, V. Audinot, G. Ferry, and P. Delagrange Molecular tools to study melatonin pathways and actions Trends Pharmacol. Sci. 26 2005 412 419 (Pubitemid 41039217)
25. A.K. Jaiswal Human NAD(P)H:quinone oxidoreductase 2. Gene structure, activity, and tissue-specific expression J. Biol. Chem. 269 1994 14502 14508
26. M. Ettaoussi, B. Peres, F. Klupsch, P. Delagrange, J.A. Boutin, P. Renard, D.H. Caignard, P. Chavatte, P. Berthelot, D. Lesieur, and S. Yous Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3 Bioorg. Med. Chem. 16 2008 4954 4962 (Pubitemid 351625889)
27. V. Leclerc, S. Yous, P. Delagrange, J.A. Boutin, P. Renard, and D. Lesieur Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3) J. Med. Chem. 45 2002 1853 1859 (Pubitemid 34415381)
28. V. Leclerc, M. Ettaoussi, M. Rami, A. Farce, J.A. Boutin, P. Delagrange, D.H. Caignard, P. Renard, P. Berthelot, and S. Yous Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT(3) Eur. J. Med. Chem. 2011
29. L. Formentini, F. Moroni, and A. Chiarugi Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo Biochem. Pharmacol. 77 2009 1612 1620
30. A. Schmidt, U. Bahr, and M. Karas Influence of pressure in the first pumping stage on analyte desolvation and fragmentation in nano-ESI MS Anal. Chem. 73 2001 6040 6046 (Pubitemid 34042222)
31. N. Tahallah, M. Pinkse, C.S. Maier, and A.J. Heck The effect of the source pressure on the abundance of ions of noncovalent protein assemblies in an electrospray ionization orthogonal time-of-flight instrument Rapid Commun. Mass Spectrom. 15 2001 596 601 (Pubitemid 32391094)
32. S. Sanglier, H. Ramstrom, J. Haiech, E. Leize, and A. Van Dorsselaer Electrospray ionization mass spectrometry analysis revealed a ∼310 kDa noncovalent hexamer of HPr kinase/phosphatase from Bacillus subtilis Int. J. Mass Spectrom. 219 2002 681 696
33. A. Tjernberg, S. Carno, F. Oliv, K. Benkestock, P.O. Edlund, W.J. Griffiths, and D. Hallen Determination of dissociation constants for protein-ligand complexes by electrospray ionization mass spectrometry Anal. Chem. 76 2004 4325 4331 (Pubitemid 39014001)
34. H. Rogniaux, S. Sanglier, K. Strupat, S. Azza, O. Roitel, V. Ball, D. Tritsch, G. Branlant, and A. Van Dorsselaer Mass spectrometry as a novel approach to probe cooperativity in multimeric enzymatic systems Anal. Biochem. 291 2001 48 61 (Pubitemid 32324523)
35. M.J. Edwards, M.A. Williams, A. Maxwell, and A.R. McKay Mass spectrometry reveals that the antibiotic simocyclinone D8 binds to DNA gyrase in a "bent-over" conformation: evidence for positive cooperativity in binding Biochemistry 50 2011 3432 3440